Report cover image

Paracetamol IV Market Growth, Size, Trends Analysis - By Indication, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Feb 06, 2025
Length 233 Pages
SKU # SPER19656783

Description

Paracetamol IV Market Introduction and Overview

According to SPER market research, ‘Global Paracetamol IV Market Size- By Indication, By Application, By End Use – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Paracetamol IV Market is predicted to reach 1150.18 million by 2034 with a CAGR of 3.72%.

Paracetamol IV (intravenous paracetamol) is a formulation of the well-known pain reliever and fever reducer paracetamol (often referred to as acetaminophen) designed for intravenous injection. It is mostly used in clinical settings to treat moderate to severe pain, particularly after surgery, and to lower fever in hospitalized patients. Because the intravenous version acts quickly, it is very beneficial for postoperative patients who require prompt and effective pain control.

Restraints:The potential for side effects like hepatotoxicity and anaphylaxis is a major barrier in the global market for intravenous paracetamol, which makes doctors use it cautiously. Ongoing research is necessary to determine acceptable dosage guidelines and ensure long-term safety. Manufacturers must focus on post-marketing surveillance and healthcare professional training in order to boost trust in its use.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Indication, By Application, By End Use.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Abbott, Aurobindo Pharma, Bristol-Myers Squibb Company, Cipla Inc., Dr Reddy's Laboratories Ltd., Lupin, Mallinckrodt (Mallinckrodt Pharmaceuticals), Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Limited, and others.

Paracetamol IV Market Segmentation:

By Indication:Based on the Indication, Global Paracetamol IV Market is segmented as; Pain, Pyrexia (Fever).

By Application:Based on the Application, Global Paracetamol IV Market is segmented as; Surgical, Non-surgical.

By End Use:Based on the End Use, Global Paracetamol IV Market is segmented as; Hospitals, Clinics, Others.

By Region:This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Table of Contents

233 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Paracetamol IV Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Paracetamol IV Market
7. Global Paracetamol IV Market, By Indication, (USD Million) 2021-2034
7.1. Pain
7.2. Pyrexia (Fever)
8. Global Paracetamol IV Market, By Application, (USD Million) 2021-2034
8.1. Surgical
8.2. Non-surgical
9. Global Paracetamol IV Market, By End Use (USD Million) 2021-2034
9.1. Hospitals
9.2. Clinics
9.3. Others
10. Global Paracetamol IV Market, (USD Million) 2021-2034
10.1. Global Paracetamol IV Market Size and Market Share
11. Global Paracetamol IV Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Abbott
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Aurobindo Pharma
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Bristol-Myers Squibb Company
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Cipla Inc.
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Dr Reddy's Laboratories Ltd.
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Lupin
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Mallinckrodt (Mallinckrodt Pharmaceuticals)
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Novartis AG
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Pfizer Inc.
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Sanofi
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Sun Pharmaceutical Industries Limited
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us